Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon Alfa-2a Plus Ribavirin in Genotype 2 Chronic Hepatitis C
NCT00532701Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2007
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV), sponsored by National Taiwan University Hospital. Started Nov 2007; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00532701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532701.